Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
SFN 2010 Press Release: Validation of Extracellular Tau Oligomer Target
Home
>
News
>
SFN 2010 Press Release: Validation of Extracellular Tau Oligomer Target
Print
Oligomerix
>
News
>
SFN 2010 Press Release: Validation of Extracellular Tau Oligomer Target
SFN 2010 Press Release: Validation of Extracellular Tau Oligomer Target
Post navigation
Previous Post
Oligomerix Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer’s Disease
Next Post
Oligomerix, Inc. Completes $2 Million Series A Financing
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
